Literature DB >> 1499934

Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infection.

S L Hazell1, J W Eichberg, D R Lee, L Alpert, D G Evans, D J Evans, D Y Graham.   

Abstract

Baboons (Papio sp.) and chimpanzees (Pan troglodytes) were screened for the presence of Helicobacter pylori. The gastric mucosae of the baboons were colonized by large spiral bacteria. However, a group of adult chimpanzees were identified that were free of spiral gastric bacteria, with five animals being recruited into an H. pylori challenge study. These animals were inoculated orogastrically with one of four strains of H. pylori and followed for up to 26 weeks. H. pylori was established in one of these animals during a primary challenge and in two other animals on secondary challenge. It was shown that the chimpanzee can be infected with H. pylori and that the inflammatory response in these animals mimics that seen in humans. Infection was marked by an antibody response to H. pylori-specific antigens in two animals. It was observed that H. pylori antibody-negative chimpanzees had no apparent infection by H. pylori or related bacteria. Thus serological screening of chimpanzees can be used to identify candidate animals for further evaluation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499934     DOI: 10.1016/0016-5085(92)90016-r

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis.

Authors:  Masaaki Kodama; Kazunari Murakami; Ryugo Sato; Tadayoshi Okimoto; Akira Nishizono; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  PCR detection of colonization by Helicobacter pylori in conventional, euthymic mice based on the 16S ribosomal gene sequence.

Authors:  J G Smith; L Kong; G K Abruzzo; C J Gill; A M Flattery; P M Scott; D Bramhill; C Cioffe; C M Thompson; K Bartizal
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans.

Authors:  Zhannat Z Nurgalieva; Margaret E Conner; Antone R Opekun; Carl Q Zheng; Susan N Elliott; Peter B Ernst; Michael Osato; Mary K Estes; David Y Graham
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease.

Authors:  A Dubois; D E Berg; E T Incecik; N Fiala; L M Heman-Ackah; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 5.  Natural pathology of the captive chimpanzee (Pan troglodytes): A 35-year review.

Authors:  Shyamesh Kumar; Hannah Laurence; Michael A Owston; R Mark Sharp; Priscilla Williams; Robert E Lanford; Gene B Hubbard; Edward J Dick
Journal:  J Med Primatol       Date:  2017-05-23       Impact factor: 0.667

6.  gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization.

Authors:  K J McGovern; T G Blanchard; J A Gutierrez; S J Czinn; S Krakowka; P Youngman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats.

Authors:  L K Handt; J G Fox; I H Stalis; R Rufo; G Lee; J Linn; X Li; H Kleanthous
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

8.  Characterization and presumptive identification of Helicobacter pylori isolates from rhesus monkeys.

Authors:  E S Drazek; A Dubois; R K Holmes
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate.

Authors:  C T Stadtländer; J D Gangemi; S S Khanolkar; C M Kitsos; H E Farris; L K Fulton; J E Hill; F K Huntington; C K Lee; T P Monath
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.